Condition: Systemic Lupus Erythematosus (SLE) · Lupus Nephritis · Neuropsychiatric Systemic Lupus Erythematosus · Sponsor: Lupus Research Alliance
The purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct of future research on Systemic Lupus Erythematosus (SLE), including Lupus Nephritis (LN).
This description comes directly from the study's public registry record.
Lupus Nexus Director · 646-884-6084 · lupusnexus@lupusresearch.org
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham | Birmingham, Alabama, United States | Recruiting |
| University of Arizona | Tucson, Arizona, United States | Recruiting |
| Wallace Rheumatic Studies Center | Beverly Hills, California, United States | Recruiting |
| UCLA | Los Angeles, California, United States | Not Yet Recruiting |
| Georgetown University | Washington D.C., District of Columbia, United States | Not Yet Recruiting |
| University of Miami | Miami, Florida, United States | Recruiting |
| Emory University | Atlanta, Georgia, United States | Recruiting |
| University of Chicago | Chicago, Illinois, United States | Recruiting |
| Brigham and Women's Hospital | Boston, Massachusetts, United States | Recruiting |
| University of Massachusetts Memorial Health | Worcester, Massachusetts, United States | Recruiting |
| Washington University | St Louis, Missouri, United States | Recruiting |
| The Feinstein Institutes for Medical Research | Manhasset, New York, United States | Recruiting |
+ 13 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05934149